Vanguard Group
LHDX

Vanguard Group’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Vanguard Group’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-623,488
Closed -$69.3K – 4613
2022
Q4 		$69.3K Sell
623,488
-8,279
-1% -$5.28K ﹤0.01% 4420
2022
Q3 		$669K Hold
631,767
– – ﹤0.01% 4133
2022
Q2 		$1.18M Hold
631,767
– – ﹤0.01% 4027
2022
Q1 		$2.26M Buy
631,767
+119,929
+23% +$589K ﹤0.01% 3907
2021
Q4 		$4.41M Buy
511,838
+63,384
+14% +$403K ﹤0.01% 3683
2021
Q3 		$3.41M Buy
448,454
+20,500
+5% +$173K ﹤0.01% 3863
2021
Q2 		$2.84M Sell
427,954
-206,948
-33% -$1.3M ﹤0.01% 3856
2021
Q1 		$7.68M Buy
+634,902
New +$12.6M ﹤0.01% 3306

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return